Arctic Therapeutics

Iceland - ReykjavikBiotechnologySponsors Visas

Focus: Arctic Therapeutics is a precision medicine biotech company leveraging genetic information to develop therapies for rare diseases. The company operates from Iceland with a diversified pipeline spanning rare diseases, ophthalmology, and infectious disease indications.

Rare Diseases

Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago

Open Jobs

3+3 this month

Stable — net +3 jobs in 30d

3 added, 0 removed. Backfill posture.

Should You Work at Arctic Therapeutics?

AI assessment

Arctic Therapeutics presents an intriguing early-stage biotech opportunity with novel science, but severe transparency gaps and lack of hiring signals suggest the company may face funding or operational challenges requiring due diligence before committing.

Why Work Here

Opportunity to work on precision medicine platform with applications across multiple therapeutic areas including rare diseases with high unmet need

Data completeness

2/9 — Limited

Company HealthStrong

Pipeline

Mid-stage

2 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Supervised home-based exercise

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT05164718The Norwegian Exercise in Atrial Fibrillation Trial

N/A

Help build intelligence for Arctic Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Diversified pipeline with programs across multiple clinical phases (Phase 1-4) offering visibility into development timelines

Novel modality exploration including fecal microbiota transplantation for Alzheimer's disease positions company at innovation frontier

Watch Out For

No active job openings reported; hiring visibility is currently opaque with zero open positions listed
Complete absence of public financial data, funding information, and employee count raises questions about company stability and capital runway
No published research output (0 publications) and minimal public presence limits ability to assess scientific credibility and team expertise

Generated by Claude from Arctic Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Carbohydrates

Porphyria, Acute Intermittent

N/A

Clinical Trials (1)

NCT06273644Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment

N/A

3D acquisition of maxillofacial characteristics

Obstructive Sleep Apnea

N/A

Clinical Trials (1)

NCT03632382Non-invasive Device for the Screening and Diagnosis of Sleep Apnea Syndrome

N/A

Interdisciplinary complex intervention

Chronic Fatigue Syndrome

N/A

Clinical Trials (1)

NCT05130099A Complex Intervention for Chronically Fatigued Lymphoma Survivors

N/A

AI-guided surgery

Glioblastoma

N/A

Clinical Trials (1)

NCT05735171Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence

N/A

CoreDISTParticipation

Multiple Sclerosis

N/A

Clinical Trials (1)

NCT06110468Physical Function, Health and Employment for People With Multiple Sclerosis

N/A

NSAC - rapid

Musculoskeletal Disorder

N/A

Clinical Trials (1)

NCT05310695A Multicentre Randomised Controlled Trial of the Norwegian Health in Work Service. The NSAC Efficacy Study

N/A

Psorax35

Psoriasis Vulgaris

N/A

Clinical Trials (1)

NCT03359577Clinical Study to Investigate Psorax35 Supplementation in Patients With Psoriasis

N/A

No intervention is planned

Quality of Care During Childbirth

N/A

Clinical Trials (1)

NCT04847336Improving MAternal Newborn carE In the in the WHO European Region During COVID-19 Pandemic

N/A

Speech of Kids After Neonatal Encephalopathy

HIE - Hypoxic - Ischemic Encephalopathy

N/A

Clinical Trials (1)

NCT07136636Speech of Kids After Neonatal Encephalopathy

N/A

A 12-week interdisciplinary complex intervention

Fatigue

N/A

Clinical Trials (1)

NCT04931407A Feasibility Study in Chronically Fatigued Cancer Survivors

N/A

NSAC health only

Musculoskeletal Disorder

N/A

Clinical Trials (1)

NCT05006976A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study

N/A

Intermittent Theta Burst Stimulation

Depression, Unipolar

N/A

Clinical Trials (1)

NCT06534684The Cerebral and Cognitive Changes After Intermittent Theta Burst Stimulation (iTBS) Treatment for Depression

N/A

Goal Management Training

COVID-19

N/A

Clinical Trials (1)

NCT05494424Cognitive Rehabilitation in Post-COVID-19 Condition

N/A

Clinical Pharmacist Intervention

Severe Mental Illness

N/A

Clinical Trials (1)

NCT07597863A Study to Investigate Health Related Quality of Life With a Pharmacist Intervention Compared to Treatment as Usual in Participants With Severe Mental Illness and Substance Use Disorder Receiving Treatment From FACT Teams.

N/A

WAYA-Wilderness

Cancer

N/A

Clinical Trials (1)

NCT04761042Wilderness Program for Adolescent and Young Adult Cancer Survivors

N/A

The Back 2 School program for problematic school absenteeism

Absence

N/A

Clinical Trials (1)

NCT05647499Evaluating the Back 2 School Program in a Norwegian Setting: A Multicenter Pilot Study